TM6SF2 as a genetic risk factor for fibrosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|4|1321-1321

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.4, 2015-10, pp. : 1321-1321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TM6SF2 as a genetic risk factor for fibrosis

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1321-1321

John Wiley & Sons Inc

Access to resources Recommend Favorite

The dual and opposite role of the TM6SF2‐rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta‐analysis

By  

HEPATOLOGY, Vol. 62, Iss. 6, 2015-12 ,pp. : 1742-1756

John Wiley & Sons Inc

Access to resources Recommend Favorite

TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 8, 2015-08 ,pp. : 1959-1963

John Wiley & Sons Inc

Access to resources Recommend Favorite

PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 658-659

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Nonaspanins TM9SF2 and TM9SF4 Regulate the Plasma Membrane Localization and Signalling Activity of the Peptidoglycan Recognition Protein PGRP-LC in Drosophila

By  

Journal of Innate Immunity, Vol. 7, Iss. 1, 2014-08 ,pp. : 37-46

Karger

Access to resources Recommend Favorite